Skip to Main Content

Paper Details

Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease.
Alzheimers Dement
48
2022
ABCA1, ABCA1 gene, AD, ADNI, AMP, Alzheimer's Disease, Alzheimer's disease, CPT1A, acylcarnitines, adiponectin protein, amines, amino acids, blood, medium/, neuronal system, short-chain acylcarnitines, systemic abnormalities in metabolism
Author NameAffiliation
Minghui WangMount Sinai Center for Transformative Disease Modeling, Icahn School of Medicine at Mount Sinai, Icahn Institute of Genomics and Multiscale Biology
Kwangsik NhoIndiana University School of Medicine
Kwangsik NhoIndiana University School of Medicine
Ke HaoMount Sinai Center for Transformative Disease Modeling, Icahn School of Medicine at Mount Sinai, Icahn Institute of Genomics and Multiscale Biology
Alison M GoateRonald M. Loeb Center for Alzheimer's Disease, Icahn School of Medicine at Mount Sinai
David A BennettRush University Medical Center
David A BennettRush University Medical Center
Andrew J SaykinIndiana University School of Medicine
Andrew J SaykinIndiana University School of Medicine
Bin ZhangMount Sinai Center for Transformative Disease Modeling, Icahn School of Medicine at Mount Sinai, Icahn Institute of Genomics and Multiscale Biology
Bin ZhangMount Sinai Center for Transformative Disease Modeling, Icahn School of Medicine at Mount Sinai, Icahn Institute of Genomics and Multiscale Biology
  • 1 - 11

Datasets

Release 1.2